About Us
Enlyte News
There’s always something going on at Enlyte. Stay up to date with the latest developments.
Data shows aging workers driving up comp costs
Enlyte’s Kim Radcliffe shares insights in Business Insurance on how the aging workforce is driving a surge in comp claim costs. Learn why musculoskeletal injuries, comorbidities, and slower recovery times among older workers are reshaping physical medicine strategies.
Tort Reform Heats Up as States Confront Hidden Forces Behind Soaring Claims
Michele Hibbert shares how Enlyte helped shape key tort reform legislation featured in Risk & Insurance. See how SB 68 in Georgia is setting the tone for state-level action on rising claim costs—and what it means for the industry.
Enlyte Releases 2025 Drug Trends Report, Part 1: Opioids Down, Migraine Meds Up
Enlyte's new Drug Trends Report shows 7.8% drop in opioid use while migraine medications rise 8.7% in workers' comp claims during 2024.
Migraine meds on rise in comp despite overall drop in scripts
Enlyte report shows migraine medications gaining popularity in workers' comp while opioid prescriptions continue downward trend in 2024.
Drug Use Insights: Migraines Rise While Opioids Decline
New Enlyte report reveals shifting trends: migraine medications up 8.7%, while opioid prescriptions decline 7.8% in workers' comp claims for 2024.
Enlyte: Migraine Medications Continue Rising in Workers’ Comp
Enlyte's 2025 Drug Trends Report shows rise in migraine medications while opioid use declines in workers' compensation claims.
Enlyte Drug Trend Report: Migraine Med Use Soars in Comp Despite Overall Drop in Scripts
Despite opioids continuing its hold as the most-prescribed drug class in workers’ compensation, migraine medications and topicals are gaining ground as alternatives to pain management, according to part 1 of Enlyte’s 2025 Drug Trends Report.
See the P&C Industry From Our 360-Degree Vantage Point
In an ever-changing landscape, trusted knowledge is like gold. We’re the insiders you can count on to break down the opportunities and challenges facing the industry today, with the expertise to share actionable insights.
